The court’s order seemed to vindicate a commitment in last year’s decision in Dobbs: to leave further questions about abortion to the political process.
The order halts lower court rulings that would have restricted the drug as an appeal moves forward in a case with profound implications for abortion access and the F.D.A.’s regulatory authority.